Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Muhammed A. H. Aldabagh
Humoral Immune Factor Changes in Group of Patients With Non-Muscle Invasive Bladder Cancer Treated With Intravesical Therapy.
Journal of the faculty of medicine baghdad
Related publications
Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer
Bladder Cancer
Oncology
Urology
RRM1 Predicts Clinical Outcome of High-And Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated With Intravesical Gemcitabine Monotherapy
BMC Urology
Medicine
Reproductive Medicine
Urology
Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)
Molecular and Clinical Oncology
Cancer Research
Oncology
Editorial on the Value of an Immediate Intravesical Instillation of Mitomycin C in Patients With Non-Muscle-Invasive Bladder Cancer
Translational Andrology and Urology
Reproductive Medicine
Urology
The Effectiveness of Single Shot Intravesical Chemotherapy With Mitomycin-C in Preventing Recurrence of Non-Muscle Invasive Bladder Cancer
Journal of Gandhara Medical and Dental Science
The Role of Molecular Genetic Alterations in Sensitivity of the Adjuvant Intravesical Therapy for Non-Muscle Invasive Bladder Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Assessment of Recurrence and Progression Risk in Patients With Non-Muscle Invasive Bladder Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy
Urology
Urology
